Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DT vs GSK✓SelectedUSD · GSKDT vs GSK performance historyLatest closeAs of-1.21%11/17
Stock and ETF performance explorer

DT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-16.6%
GSK return
+58.1%
Excess return
-74.7%
Maximum drawdown
-48.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-2.3%+1.1%-1.3%
7D-0.7%-3.0%+2.3%-0.8%
30D-29.3%+0.4%-29.7%-29.3%
3M-9.3%-1.2%-8.1%-9.3%
6M+12.6%+0.9%+11.7%+12.7%
YTD-0.3%+4.0%-4.3%-1.7%
1Y-4.3%+7.3%-11.6%-5.9%
All-16.6%+58.1%-74.7%-23.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling